Dr. Charlotte Sriruttan

Charlotte Sriruttan is a South African clinical microbiologist and infectious diseases researcher whose work centers on opportunistic and emerging infections in high HIV-burden settings. Affiliated with national laboratory-based surveillance initiatives, her research integrates clinical epidemiology, molecular diagnostics, and public health to strengthen responses to serious fungal and bacterial diseases.

Her publications highlight major contributions to understanding cryptococcal disease, candidemia, and Candida auris, including antifungal resistance mechanisms and outcomes among HIV-seropositive patients. She has evaluated national reflex cryptococcal antigen screening and advanced HIV diagnostic strategies, demonstrating the impact of early detection on survival. Work on pneumococcal conjugate vaccines further reflects engagement in large-scale surveillance and vaccine impact assessment.

Additional case investigations of rare and emerging pathogens, including neoehrlichiosis and invasive free-living nematode infection, underscore expertise in molecular identification and pathogen discovery. Collectively, her scholarship advances laboratory surveillance, antimicrobial resistance monitoring, and evidence-based interventions to reduce mortality from infectious diseases in Southern Africa.